Biotech

All Articles

Vaxcyte rises on 'magnificent' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what experts named "magnificent" period 1/2 records for its own 31-valent pneumoco...

Recursion's brain disease test reveals insufficient documentation of effectiveness

.Recursion has actually discovered with a very early test of its tech-enabled technique to medicatio...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Contact it an instance of excellent chemistry: Acepodia, a biotech based upon Nobel Champion scient...

Praxis epilepsy drug reduces seizures in phase 2 trial

.Practice Precision Medicines has scored an additional midphase succeed in epilepsy this year, with ...

Three officers surrender as Dyne blog posts combined information for DMD candidate

.After getting away a professional hold many years back, Dyne Therapeutics has actually uncovered ne...

Arrowhead fires off period 3 information in rare metabolic ailment ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its hand ahead of a potential face-off with Ionis,...

Pfizer, Valneva reveal lyme disease shot effective for second enhancer

.Pfizer and Valneva may possess about two more years to stand by just before they produce the very f...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a conversation along with Ayla Ellison, Ferocious Biotech Managing Editor as well as...

New information demonstrate how Bayer's asundexian failed to avoid movements

.Bayer put on hold the stage 3 trial for its own element XIa inhibitor asundexian late last year aft...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA, execs...